Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near New Haven, CT

17 studies for Crohn's Disease are recruiting at 21 sites within 50 miles of New Haven, Connecticut, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near New Haven.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near New Haven

Showing 17 studies, nearest first.
  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Center/Yale-New Haven Hospital (New Haven, CT); Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Yale University School of Medicine-Digestive Disease ( Site 5019) (New Haven, CT); Northwell Mather Hospital ( Site 5138) (Port Jefferson, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Yale University School of Medicine /ID# 266786 (New Haven, CT); Danbury Hospital, Western Connecticut Health Network /ID# 265556 (Danbury, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Yale University Digestive Disease-Site Number: 8400108 (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University School of Medicine (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Medical Research Center of Connecticut (Hamden, CT); Westchester Putnam Gastroenterology (Carmel, NY)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Medical Research Center of Connecticut, LLC (Hamden, CT)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    NCT06651281

    • Phase 3
    • Ages Any age
    • Sex: All

    Nearest site: Connecticut Clinical Research Institute ( Site 0297) (Bristol, CT)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    NCT04779320

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Stony Brook University Medical Center (Stony Brook, NY)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest site: Connecticut Children's Medical Center (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    NCT05509777

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Connecticut Children's Medical Center (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT05781152

    • Phase 4
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Connecticut Children's Medical Center (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    NCT06332534

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Connecticut Children's Medical Center - Hartford /ID# 262256 (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

    NCT07224113

    • Observational
    • Ages 10 to 21 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Connecticut Children's Medical Center (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Westchester Putnam Gastroenterology PC (Carmel, NY)

    Distance to nearest recruiting site
    ~40 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Westchester Putnam Gastroenterology (Carmel, NY)

    Distance to nearest recruiting site
    ~40 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.